A regulatory submission can become complicated long before it reaches a health authority, particularly when scientific writing, quality control, publishing and project management sit with different vendors, each operating on its own timelines. For biotech companies with lean internal teams, coordinating these moving parts can consume valuable time and leave sponsors responsible for connecting the dots. Aroga Biosciences was built around addressing this challenge by bringing the key elements of regulatory writing and submission execution under one roof.
The company gets its name from a Sanskrit word meaning “free from disease,” reflecting its connection to the broader pursuit of better health outcomes. The San Diego-based company supports life sciences organizations from early development through regulatory submissions, combining medical writing, scientific quality control, regulatory operations and project management within a connected service model. Aroga’s approach reflects the understanding that preparing a submission requires scientific interpretation, consistency across deliverables, careful coordination and attention to the requirements governing how information reaches regulators.
Connecting Scientific Understanding With Regulatory Execution
Aroga’s medical writing capabilities span clinical, regulatory, safety, chemistry, manufacturing and controls (CMC), nonclinical and publication writing. It works across document types that include investigational new drug (IND) applications, investigator brochures, clinical study protocols, clinical study reports and regulatory summaries.
At the heart of this work is a team of PhDs, PharmDs and other advanced-degree professionals whose scientific training helps them engage with the substance of the data, rather than concentrating only on presentation. This foundation informs how evidence is organized, interpreted and communicated for its intended audience, with the aim of producing documents that are scientifically sound and aligned with regulatory expectations.
“We recognized that sponsors were often struggling to coordinate multiple vendors and freelancers for medical writing, QC, publishing and submissions. Our goal was to create a one-stop shop that brings these services together under one roof, offering clients a more seamless experience built on consistent quality, clear communication and shared accountability,” says Krithi Bindal, founder and president .
Scientific quality control serves as a complementary layer, with data verification, editorial review and assessments of regulatory readiness helping teams evaluate accuracy, formatting, consistency and adherence to style requirements. Aroga also describes the use of internal standard operating procedures, templates and client-specific processes to maintain consistency across projects, while continued training and participation in industry forums help its professionals remain engaged with developments in scientific communication and regulatory practice.
From Document Development To Submission
Aroga’s regulatory operations offering extends the work beyond writing and review into document-level publishing, electronic Common Technical Document (eCTD) preparation, validation and health authority submission support. Documents must be appropriately formatted, hyperlinked and bookmarked, with consistency maintained across modules and technical requirements addressed before filing. By bringing these activities into the same workflow, it aims to reduce handoffs and keep scientific content connected to the technical requirements of submission.
-
We recognized that sponsors were often struggling to coordinate multiple vendors and freelancers for medical writing, QC, publishing and submissions. Our goal was to create a one-stop shop that brings these services together under one roof, offering clients a more seamless experience built on consistent quality, clear communication and shared accountability.
The company also supports documents prepared by a sponsor’s internal team or another service provider, allowing clients to engage Aroga for publishing and submission assistance without outsourcing the entire writing process. This flexibility is complemented by project management that covers timeline development, cross- functional coordination, proactive issue resolution and oversight from initiation through submission.
A further element of the offering is document delivery and copyright management, through which Aroga helps clients obtain and manage published scientific literature using enterprise licensing supported by the Copyright Clearance Center. Its services include article delivery and oversight of referenced publications, figures, tables and other copyrighted material, helping sponsors address permissions and maintain documentation that supports compliance and audit readiness.
Technology supports these workflows through consistency-checking tools, project-management systems like Smartsheet and validation tools used in publishing quality control. Rather than presenting technology as a replacement for scientific judgement, Aroga positions these tools as part of the process for improving coordination, accuracy and submission preparation.
Aroga has supported clients through complex regulatory milestones, including a first IND submission for which its team developed key regulatory documents from scratch while navigating shifting strategies, evolving scientific data and tight timelines. In another example, its teams coordinated medical writing, quality control, regulatory operations and project management to support a critical FDA submission during a holiday period, coordinating across time zones to meet the deadline without compromising on quality.
For Aroga, the objective is to bring scientific understanding and operational execution together while remaining responsive to the needs of individual sponsors. By connecting document development with quality control, publishing and submission support, the company aims to make the regulatory process more coordinated and manageable for life sciences teams working to advance new therapies.
Regulatory Submissions Require More than Medical Writing
A clinical development team may have completed its core reports yet still face weeks of reconciliation before a regulatory filing. Data tables may not match the narrative, and document versions may diverge. Publishing requirements can expose problems that earlier reviews missed. When sponsors hire separate providers for writing and submission preparation, the division of responsibility can make corrections slower. The contracting decision extends beyond securing qualified writers to determining who will resolve discrepancies before they affect the filing schedule.
Scientific judgment is difficult to judge from a writing sample alone. Regulatory writers must understand how study results support the conclusions presented, including where the evidence has limits. A polished clinical study report is of little use if its interpretation departs from the underlying data or conflicts with a regulatory summary. Provider assessments should examine the scientific qualifications of assigned personnel and how those individuals work with clinical and regulatory specialists. The proposed review process should also show how unresolved scientific questions reach the sponsor rather than disappear into successive document revisions.
Quality control requires a distinct scope. Editorial correction does not replace verification of numbers against source materials, checks across related documents or confirmation that required conventions have been applied. Sponsors should establish who owns each review and whether quality checks occur during drafting or only after documents are considered complete. Late discovery of an inconsistency can force changes across multiple submission components. Dedicated reviewers may add cost, but an unspecified promise of accuracy offers little protection against rework.
“Aroga Biosciences also supports eCTD preparation, document-level publishing, technical validation and health authority submissions, connecting approved content to filing requirements.”
The transition into publishing creates a different kind of exposure. Electronic Common Technical Document submissions depend on appropriate document structure and functioning navigation, along with technical validation. A file that has passed scientific review can still require considerable preparation before it is ready for submission. Procurement teams should establish whether the provider handles document-level publishing and validation directly or transfers approved content to a separate specialist. Handoff arrangements should specify how publishing findings return to the writers, particularly when corrections alter linked documents or affect previously approved text.
Service boundaries also need to reflect the sponsor's staffing model. Some development groups need comprehensive support beginning with protocols and extending to filing. Others retain internal authors but lack dedicated publishing personnel. An all-inclusive engagement can impose unnecessary duplication in the latter case, while a narrow contract may leave a small sponsor coordinating several separate teams. Timeline ownership and escalation procedures should be documented, along with responsibilities for copyright permissions and externally sourced scientific literature. These details influence how much work ultimately remains with the sponsor.
Aroga Biosciences combines scientific and regulatory medical writing with quality control, publishing and submission support under a coordinated service model. Its advanced-degree writing team prepares clinical and regulatory documents, while dedicated review activities cover data verification and consistency across deliverables. Aroga Biosciences also supports eCTD preparation, document-level publishing, technical validation and health authority submissions, connecting approved content to filing requirements. Clients can engage it for publishing work on documents produced internally or by another provider, without transferring the complete writing assignment. Project management supports schedules and cross-functional coordination, while its literature services address article delivery and copyright permissions. This scope is relevant to lean biotech sponsors managing interdependent submission tasks and established teams requiring dedicated publishing capacity.
...Read more
